Drugs / Vivomixx
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT05501470 | Jun → Jul 2024 | — | Institut Pasteur de Dakar | Completed | No outcome recorded |
| Phase 2 | NCT05922683 | Aug 2023 → Jun 2024 | — | Aga Khan University | Completed | No outcome recorded |
| Phase 2 | NCT04769687 | Nov 2020 → May 2023 | chronic renal failure syndrome, diabetes mellitus, noninsulin-dependent, 2 | Centre Hospitalier Universitaire de Besancon | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05083572 | Mar 2021 → Nov 2022 | immune dysregulation, neurodevelopmental defects, and colitis | Changi General Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial · 1 met primary | ||||||
| — | NCT04243148 | May 2020 → Jun 2022 | cirrhosis of liver, muscular atrophy | Sant Pau Research Institute | Completed | Met primary |
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT03518268 Comparator | Jan 2019 → Apr 2021 | breast cancer, osteoporosis | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02552862 Comparator | Sep 2016 → Dec 2017 | infectious peritonitis | Sant Pau Research Institute | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT04160767 Comparator | Jan 2019 → Jul 2021 | celiac disease | University of Milan | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vivomixx | “The primary objective of this trial is to determine if a probiotic, Vivomixx, can reduce inflammation and epithelial damage in pregnant women with environmental enteropathy in...” NCT05501470 ↗7“The subjects will self-administer orally two capsules of Vivomixx with room temperature water (as heat may inactivate the live bacteria, rendering it less effective) twice...” NCT05083572 ↗ |
| Modality | Other / unclassified | “Vivomixx® is a probiotic mixture of 8 proprietary strains” NCT02552862 ↗ |
| Route | Oral | “can be administered orally” NCT04769687 ↗ |